Gaas, Baby Girl -.

HRN: 22-39-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/27/2022
01/03/2023
IVT
33 Mg
24 Hrs
Neonatal Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: